ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Actinium Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$1.32+0.19 (+16.81%)
Close on Oct 19, 2026
- Market cap
- $41.46M
- P/E (TTM)
- 3.7
- Dividend yield
- –
SEC filings
40 of Actinium Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Proxy statement | DEF 14A | Nov 25, 2026 | Oct 16, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2026 | Oct 15, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 7, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 18, 2026 | SEC EDGAR |
| Current report | 8-K | May 27, 2026 | May 29, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 8, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2026 | Feb 13, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 26, 2025 | Nov 26, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Nov 26, 2025 | Nov 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 9, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 9, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 27, 2024 | Nov 27, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 1, 2024 | Nov 5, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Nov 27, 2024 | Nov 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 5, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2024 | Aug 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | Apr 26, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 29, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 30, 2023 | Dec 1, 2023 | SEC EDGAR |
| Proxy statement | DEF 14A | Nov 30, 2023 | Nov 9, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 2, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2023 | Aug 14, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2023 | May 15, 2023 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2022 | Mar 31, 2023 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2023 | Mar 10, 2023 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2023 | Feb 21, 2023 | SEC EDGAR |
| Current report | 8-K | Dec 30, 2022 | Dec 30, 2022 | SEC EDGAR |
| Current report | 8-K | Dec 8, 2022 | Dec 9, 2022 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 8, 2022 | Nov 21, 2022 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2022 | Nov 14, 2022 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2022 | Oct 31, 2022 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2022 | Aug 12, 2022 | SEC EDGAR |
| Current report | 8-K | Jun 28, 2022 | Jun 29, 2022 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2022 | May 13, 2022 | SEC EDGAR |